Papers
5
Total Citations
110
H-Index
4
About
Dr. Shikha Agrawal is a leading urologic surgeon and researcher whose work is reshaping the surgical management of prostate cancer. Her primary research focuses on advancing robot-assisted radical prostatectomy (RARP) and exploring novel therapeutic combinations, particularly the integration of irreversible electroporation (IRE) with immune modulation. Dr. Agrawal’s major contributions include demonstrating the safety and feasibility of PSMA-radioguided surgery during primary RARP to improve intraoperative detection of lymph node metastases (51 citations), and providing critical insights into age-related urinary continence outcomes through a large multi-institutional study (26 citations). She has also pioneered salvage RARP following focal IRE ablation, establishing its oncological and functional viability for recurrent disease (16 citations). Her groundbreaking IRE-IMMUNO study (13 citations) revealed that IRE can downregulate immune suppression and induce systemic anti-tumour T-cell activation—a finding with profound implications for combining focal therapy with immunotherapy. Dr. Agrawal’s work bridges surgical precision and immunology, positioning her at the forefront of personalized, minimally invasive prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5